Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.KKR to acquire Pfizer Capsugel business for $2.375bn
Capugel is a provider of hard capsules and an innovator in drug delivery systems for the pharmaceutical, OTC and health and nutrition industries. Folllowing the transaction, all Pfizer
Capugel is a provider of hard capsules and an innovator in drug delivery systems for the pharmaceutical, OTC and health and nutrition industries. Folllowing the transaction, all Pfizer
The decision is followed by renewal inspection by a team from the regulatory agency. Suven Life Sciences is an India-based contract research and manufacturing services (CRAMS) provider, which
The active categories which the new patent covers include opiate and opiate derivatives such as buprenorphine and naloxone, anti-emetics such as ondansetron and granisetron hydrochloride, analgesics such as
The study enrolled healthy male and female volunteers, who received a single dose of Bendavia administered as an intravenous infusion over an extended period. Safety trial from the
MEDai, a subsidiary of Elsevier, offers solutions for the improvement of healthcare delivery. AtlantiCare will use MEDai’s Risk Navigator solutions in conjunction with its patient-centered medical home model
Latanoprost Ophthalmic Solution, 0.005% is the generic version of Pharmacia and Upjohn’s Xalatan Ophthalmic Solution, an eyedrop that lowers pressure in the eye. Latanoprost reduces pressure in the
Prior to joining Depomed, Schoeneck worked as the CEO of BrainCells, a biopharmaceutical company in San Diego, California. Before BrainCells, Schoeneck was the president and CEO of a
The three new grants, combined with other grants renewed for 2011, brings total non dilutive R&D funding for 2011 to $4.8m, with an additional $3.3m committed for future
RE-LY is a PROBE (prospective, randomised, open-label with blinded endpoint evaluation), designed to compare two fixed doses of the oral direct thrombin inhibitor dabigatran (110mg and 150mg bid)
Sertech prepares patient instructional leaflets for its US pharmaceutical customers. The acquired company will immediately change its trading name to CCL Label. CCL Label manufactures similar products at